NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)

被引：0
|
作者：
Guirado, M. [1 ]
Majem, M. [2 ]
Massuti Sureda, B. [3 ]
de las Penas Bataller, R. [4 ]
Ortega Granados, A. L. [5 ]
Isla Casado, M. D. [6 ]
Domine Gomez, M. [7 ]
Marse Fabregat, R. [8 ]
Sala, M. A. [9 ]
Paredes Lario, A. [10 ]
Moran Bueno, M. T. [11 ]
Vazquez Estevez, S. [12 ]
Coves Sarto, J. [13 ]
Gonzalez-Larriba, J. L. [14 ]
Sanchez Torres, J. M. [15 ]
Vicente, D. [16 ]
Farre Bernado, N. [17 ]
Fernandez-Fornos, L. [18 ]
Varcarcel, F. [19 ]
Provencio, M. [20 ]
机构：
[1] Hosp Gen Univ Elche, Dept Med Oncol, Elche, Spain
[2] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain
[3] Hosp Gen Univ Alicante, Dept Med Oncol, Alicante, Spain
[4] Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain
[5] Univ Jaen, Complejo Hosp Jaen, Oncol Med, Jaen, Spain
[6] Hosp Clin Univ Lozano Blesa, Dept Med Oncol, Zaragoza, Spain
[7] Univ Hosp Fdn Jimenez Diaz, Dept Med Oncol, Madrid, Spain
[8] Hosp Univ Son Espases, Dept Med Oncol, Palma De Mallorca, Spain
[9] Hosp Basurto, Dept Med Oncol, Bilbao, Spain
[10] Hosp Univ Donostia, Med Oncol, San Sebastian, Spain
[11] Hosp Badalona Germans Trias & Pujol, Dept Med Oncol, Catalan Inst Oncol ICO Badalona, Badalona, Spain
[12] Hosp Xeral Calde Lugo, Dept Med Oncol, Lugo, Spain
[13] Hosp Son Llatzer, Dept Med Oncol, Palma De Mallorca, Spain
[14] Hosp Clin Univ San Carlos, Dept Med Oncol, Madrid, Spain
[15] Hosp Univ La Princesa, Dept Med Oncol, Madrid, Spain
[16] Hosp Univ Virgen Macarena, Dept Med Oncol, Seville, Spain
[17] Hosp Santa Creu & Sant Pau, Dept Radiotherap Oncol, Barcelona, Spain
[18] Hosp Gen Univ Alicante, Dept Radiotherap Oncol, Alicante, Spain
[19] Hosp Univ Puerta de Hierro Majadahonda, Dept Radiotherap Oncol, Madrid, Spain
[20] Hosp Univ Puerta de Hierro Majadahonda, Med Oncol, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1461P
引用
收藏
页码：594 / 594
页数：1
相关论文
共 50 条
  • [1] Preliminar analysis of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC): NORA trial (GECP 15/02)
    Majem Tarruella, M.
    Isla Casado, L.
    Guirado, M.
    Massuti Sureda, B.
    Ortega Granados, A. L.
    Marse Fabregat, R.
    Domine Gomez, M.
    de las Penas, R.
    Moran Bueno, M. T.
    Vazquez Estevez, S.
    Sala Gonzalez, M. A.
    Coves Sarto, J.
    Sanchez-Torres, J. M.
    Vicente Baz, D.
    Gonzalez-Larriba, J.
    Paredes, A.
    Farre, N.
    Fernandez Fornos, L.
    Mena, A.
    Provencio Pulla, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] NORA trial (GECP 15/02): First efficacy results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC).
    Isla, Dolores
    Majem, Margarita
    Guirado, Maria
    Massuti, Bartomeu
    De Las Penas, Ramon
    Granados, Ana Laura Ortega
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] INTERIM ANALYSIS OF THE SPANISH LUNG CANCER GROUP (SLCG) RANDOMIZED PHASE II TRIAL OF THORACIC RADIOTHERAPY (RT) CONCURRENT WITH CISPLATIN (P) PLUS ORAL VINORELBINE (OV) OR ETOPOSIDE (E) FOR UNRESECTABLE LOCALLY ADVANCED (LA) STAGE III NON-SMALL CELL LUNG CANCER (NSCLC). (GECP10/02)
    Isla, Dolores
    De Las Penas, Ramon
    Martinez-Banaclocha, Natividad
    Massuti, Bartomeu
    Angeles Sala, Maria
    Bover, Isabel
    Marse, Raquel
    Insa, Amelia
    Moran, Teresa
    Artal, Angel
    Diz, Pilar
    Gomez-Codina, Jose
    Laura Ortega, Ana
    Gutierrez, Vanesa
    Munoz, Jose
    Alvarez De Mon, Melchor
    Camps, Carlos
    Garcia-Gomez, Ramon
    Jurado, Jose M.
    Ponce-Aix, Santiago
    Provencio, Mariano
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S408 - S408
  • [4] Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC)
    Hansen, O.
    Knap, M.
    Khalil, A.
    Nyhus, C.
    Brink, C.
    Hoffmann, L.
    Schytte, T.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S663 - S663
  • [5] Randomized phase II trial (RENO): Efficacy results of oral vinorelbine or etoposide combined with cisplatin in chemo-radiotherapy treatment of locally advanced NSCLC (LA-NSCLC)-SLCG 10/02.
    Provencio, Mariano
    de las Penas, Ramon
    Insa, Amelia
    Martinez-Banaclocha, Natividad
    Fabregat, Raquel Marse
    Sanchis, Pilar Mut
    Moran, Teresa
    Sala, Angeles
    Massuti, Bartomeu
    Ortega, Ana Laura
    Jurado, Jose Miguel
    Gomez-Codina, Jose
    Diz, Pilar
    Artal-Cortes, Angel
    Calderon, Vanesa Gutierrez
    Vazquez, Maria Francisca
    Vinolas, Nuria
    Quintana, Miguel Angel Munoz
    Garcia-Gomez, Ramon
    Isla, Dolores
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Concomitant radiotherapy (RT) with docetaxel for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)
    Fuente, N.
    Mane, J. M.
    Rubio, I.
    Carrera, S.
    Martinez-Bueno, A.
    Lopez de Argumedo, G.
    Ferreiro, J.
    Abon, G.
    Garrido, P.
    Lopez-Vivanco, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] OUTCOMES OF RADIOTHERAPY ALONE FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC) IN PATIENTS UNFIT FOR CHEMO-RADIOTHERAPY
    Gouran-Savadkoohi, Mohammad
    Pond, Greg
    Quan, Kimmen
    Mesci, Aruz
    Swaminath, Anand
    Okawara, Gordon
    Ribeiro, Derek
    Chow, Tom
    Wright, James
    Tsakiridis, Theos
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S39 - S39
  • [8] Concurrent chemo-radiotherapy in locally advanced non-small cell lung cancer (NSCLC): A multicenter randomized phase II study
    Bouillet, T
    Diana, C
    Pailler, M
    Gozy, M
    Labrune, S
    Gervais, R
    Brechot, J
    Breau, J
    Chinet, T
    Morere, J
    LUNG CANCER, 2005, 49 : S166 - S167
  • [9] Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)
    Garassino, I
    Campagnoli, E.
    Cavina, R.
    Soto, Parra H. J.
    De Vincenzo, F.
    Zucali, P. A.
    Salamina, S.
    Ceresoli, G. L.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI20 - XI20
  • [10] Safety and Efficacy Trial of Cisplatin (P) and Vinorelbine (V) Followed by Gefitinib (G) and Concurrent Thoracic Radiotherapy (TRT) for Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) JCOG0402
    Ohe, Yuichiro
    Ishikura, Satoshi
    Yokoyama, Akira
    Atagi, Shinji
    Shibata, Taro
    Tamura, Tomohide
    Saijo, Nagahiro
    Fukuoka, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S401 - S402
12345